Sarah Greenlee

1.1k total citations
13 papers, 827 citations indexed

About

Sarah Greenlee is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Sarah Greenlee has authored 13 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Sarah Greenlee's work include Advanced biosensing and bioanalysis techniques (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and Muscle Physiology and Disorders (2 papers). Sarah Greenlee is often cited by papers focused on Advanced biosensing and bioanalysis techniques (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and Muscle Physiology and Disorders (2 papers). Sarah Greenlee collaborates with scholars based in United States, Canada and Denmark. Sarah Greenlee's co-authors include Gene Hung, Susan M. Freier, Amber L. Southwell, Michael R. Hayden, C. Frank Bennett, Jeffrey B. Carroll, Simon C. Warby, Niels H. Skotte, Crystal N. Doty and Punit P. Seth and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Biotechnology.

In The Last Decade

Sarah Greenlee

13 papers receiving 812 citations

Peers

Sarah Greenlee

CMN

GENET

CCM

Ward Sents Belgium

Corey Braastad United States

Harry Holzmüller Germany

Haruka Hirose Japan

Aslι Küçükosmanoğlu Netherlands

Alfons Meindl Germany

Sigve Nakken Norway

Matthew R. Kaser United States

Craig M. Forester United States

Ward Sents Belgium

Sarah Greenlee

531 ×0.8

46 ×0.3

CMN

43 ×0.5

GENET

60 ×0.8

GENET

23 ×0.4

CCM

Citations per year, relative to Sarah Greenlee Sarah Greenlee (= 1×) peers Ward Sents

Countries citing papers authored by Sarah Greenlee

Since Specialization

Citations

This map shows the geographic impact of Sarah Greenlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Greenlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Greenlee more than expected).

Fields of papers citing papers by Sarah Greenlee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Greenlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Greenlee. The network helps show where Sarah Greenlee may publish in the future.

Co-authorship network of co-authors of Sarah Greenlee

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Greenlee. A scholar is included among the top collaborators of Sarah Greenlee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Greenlee. Sarah Greenlee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Post, Noah, Rosie Z. Yu, Sarah Greenlee, et al.. (2019). Metabolism and Disposition of Volanesorsen, a 2′-O-(2 methoxyethyl) Antisense Oligonucleotide, Across Species. Drug Metabolism and Disposition. 47(10). 1164–1173. 44 indexed citations

Ochaba, Joseph, Andrew F. Powers, Sarah Greenlee, et al.. (2019). A novel and translational role for autophagy in antisense oligonucleotide trafficking and activity. Nucleic Acids Research. 47(21). 11284–11303. 16 indexed citations

Shen, Wen, Cheryl Li De Hoyos, Michael T. Migawa, et al.. (2019). Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nature Biotechnology. 37(6). 640–650. 239 indexed citations

Shen, Lijiang, Brian R. Curtis, Mario A. Bourdon, et al.. (2018). Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2ʹ-MOE-Modified Antisense Oligonucleotide. Toxicological Sciences. 164(2). 613–626. 26 indexed citations

Donner, Aaron J., Thomas A. Bell, Sarah Greenlee, Mark J. Graham, & Rosanne M. Crooke. (2018). Characterization of the Activity and Distribution of a 2′-O-Methoxyethyl-Modified Antisense Oligonucleotide in Models of Acute and Chronic Kidney Disease. Nucleic Acid Therapeutics. 28(5). 297–306. 11 indexed citations

Crosby, Jeff, Chenguang Zhao, Chong Jiang, et al.. (2017). Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice. Journal of Cystic Fibrosis. 16(6). 671–680. 68 indexed citations

Tasfaout, Hichem, Shuling Guo, Christine Kretz, et al.. (2017). Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice. Nature Communications. 8(1). 15661–15661. 72 indexed citations

Donner, Aaron J., Edward V. Wancewicz, Heather Murray, et al.. (2017). Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the Liver. Nucleic Acid Therapeutics. 27(4). 209–220. 15 indexed citations

Shemesh, Colby S., Rosie Z. Yu, Hans Gaus, et al.. (2016). Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys. Molecular Therapy — Nucleic Acids. 5. e319–e319. 46 indexed citations

10.

Kim, Youngsoo, Jeff Hsu, Tianyuan Zhou, et al.. (2013). Abstract LB-317: Potent in vivo pharmacology of AZD9150, a next-generation, constrained ethyl-modified antisense oligonucleotide targeting STAT3 in multiple preclinical cancer models.. Cancer Research. 73(8_Supplement). LB–317. 2 indexed citations

11.

Burel, Sebastien A., Todd Machemer, Hiroki Kato, et al.. (2012). Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response. Journal of Pharmacology and Experimental Therapeutics. 342(1). 150–162. 25 indexed citations

12.

Carroll, Jeffrey B., Simon C. Warby, Amber L. Southwell, et al.. (2011). Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin. Molecular Therapy. 19(12). 2178–2185. 225 indexed citations

13.

Wang, Susanna S., Weibin Shi, Xuping Wang, et al.. (2007). Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice. Arteriosclerosis Thrombosis and Vascular Biology. 27(12). 2671–2676. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact